Ann Raldow, MD
UCLA / Jonsson Comprehensive Cancer Center · Associate Professor
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Ann Raldow, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:23 UTC. Open this list on ClinicalTrials.gov
- N/ANCT07671768 · Magnetic Resonance-Guided Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Tumors, ONE SHOT TrialJonsson Comprehensive Cancer Center · not yet recruiting · Metastatic Malignant Solid Neoplasm · principal investigator
- Ph1/Ph2NCT03148327 · Astra Zeneca (Immuno Stereotactic Ablative Body Radiotherapy) ISABR Study: Randomized Phase I/II Study of Stereotactic Body RadiotherapyJonsson Comprehensive Cancer Center · terminated · Carcinoma, Non-Small-Cell Lung · principal investigator
- Early Ph1NCT02683200 · MRI-Guided Stereotactic Body Radiation Therapy in Treating Patients With Liver Metastases or Liver CancerJonsson Comprehensive Cancer Center · completed · Adult Hepatocellular Carcinoma, Metastatic Malignant Neoplasm in the Liver · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:23 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in non-small cell lung cancer.